{{Infobox drug | image = Pirtobrutinib.svg | width = | alt = | caption = <!-- Clinical data --> | pronounce = | tradename = Jaypirca | Drugs.com = {{drugs.com|monograph|pirtobrutinib}} | MedlinePlus = a623012 | DailyMedID = Pirtobrutinib | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_AU_comment= | pregnancy_category= | routes_of_administration= [[By mouth]] | class = [[Protein kinase inhibitor]] | ATC_prefix = L01 | ATC_suffix = EL05 | ATC_supplemental= <!-- Legal status --> | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled --> | legal_AU_comment= | legal_BR = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F --> | legal_BR_comment= | legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_CA_comment= | legal_DE = <!-- Anlage I, II, III or Unscheduled --> | legal_DE_comment= | legal_NZ = <!-- Class A, B, C --> | legal_NZ_comment= | legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C --> | legal_UK_comment= | legal_US = Rx-only | legal_US_comment= | legal_EU = Rx-only | legal_EU_comment= <ref name="Jaypirca EPAR">{{cite web | title=Jaypirca EPAR | website=[[European Medicines Agency]] (EMA) | date=20 November 2023 | url=https://www.ema.europa.eu/en/medicines/human/EPAR/jaypirca | access-date=22 November 2023 | archive-date=22 November 2023 | archive-url=https://web.archive.org/web/20231122061321/https://www.ema.europa.eu/en/medicines/human/EPAR/jaypirca | url-status=live }}</ref><ref>{{cite web | title=Jaypirca Product information | website=Union Register of medicinal products | date=31 October 2023 | url=https://ec.europa.eu/health/documents/community-register/html/h1738.htm | access-date=22 November 2023 | archive-date=22 November 2023 | archive-url=https://web.archive.org/web/20231122061342/https://ec.europa.eu/health/documents/community-register/html/h1738.htm | url-status=live }}</ref> | legal_UN = <!-- N I, II, III, IV / P I, II, III, IV --> | legal_UN_comment= | legal_status = <!-- For countries not listed above --> <!-- Pharmacokinetic data --> | bioavailability = | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life= | duration_of_action= | excretion = <!-- Identifiers --> | CAS_number = 2101700-15-4 | CAS_supplemental= | PubChem = 129269915 | IUPHAR_ligand = | DrugBank = DB17472 | ChemSpiderID = 114875989 | UNII = JNA39I7ZVB | KEGG = D12050 | ChEBI = 229212 | ChEMBL = 4650485 | NIAID_ChemDB = | PDB_ligand = Y7W | synonyms = LOXO-305 <!-- Chemical and physical data --> | IUPAC_name = 5-amino-3-[4-[<nowiki/>[(5-fluoro-2-methoxybenzoyl)amino]methyl]phenyl]-1-[(2S)-1,1,1-trifluoropropan-2-yl]pyrazole-4-carboxamide | C = 22 | H = 21 | F = 4 | N = 5 | O = 3 | SMILES = COC1=C(C=C(F)C=C1)C(=O)NCC1=CC=C(C=C1)C1=NN([C@@H](C)C(F)(F)F)C(N)=C1C(N)=O | StdInChI = 1S/C22H21F4N5O3/c1-11(22(24,25)26)31-19(27)17(20(28)32)18(30-31)13-5-3-12(4-6-13)10-29-21(33)15-9-14(23)7-8-16(15)34-2/h3-9,11H,10,27H2,1-2H3,(H2,28,32)(H,29,33)/t11-/m0/s1 | StdInChI_comment= | StdInChIKey = FWZAWAUZXYCBKZ-NSHDSACASA-N | density = | density_notes = | melting_point = | melting_high = | melting_notes = | boiling_point = | boiling_notes = | solubility = | sol_units = | specific_rotation= }}
